Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease
Authors:
- Pascal de GrootePGPascal de Groote
- Eric MasyEMEric Masy
- Christophe Di PompeoCPChristophe Di Pompeo
- Alain MillaireAMAlain Millaire
- Olivier BouillanneOBOlivier Bouillanne
- Brigitte JudeBJBrigitte Jude
- Philippe DewaillyPDPhilippe Dewailly
- Gérard DuclouxGDGérard Ducloux
- 1 December 2000
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (8) , 635-641
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β 2 -Glycoprotein ICirculation, 1998
- Atherosclerosis and the antiphospholipid syndrome: A link unravelled?Lupus, 1998
- EditorialLupus, 1997
- Involvement of beta2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophagesClinical and Experimental Immunology, 1997
- Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies [see comments]Blood, 1994
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- 'Primary', 'Secondary' and Other Variants of the Antiphospholipid SyndromeLupus, 1994
- Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosusThe Lancet, 1993
- Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE DisordersAnnals of Internal Medicine, 1990